$PHAT Cashflow Statement | Understand Stock

$PHAT

$5.99 +$0.05 (0.84%) Close

$PHAT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Stock-based compensation
Issuance of PIK interest debt
Accrued interest on revenue interest financing liability
Accrued payment-in-kind interest on debt
Accrued interest on revenue interest financing liability, net of payments
Amortization of debt discount
Inventory reserve
Other
Changes in operating assets and liabilities:
Prepaid expenses and other current assets
Accounts receivable, net
Accounts payable and accrued expenses
Accrued clinical trial expenses
Accrued interest
Operating right-of-use assets and lease liabilities
Inventory
Other long-term assets
Net cash used in operating activities
Cash flows from investing activities
Cash paid for property and equipment
Net cash used in investing activities
Cash flows from financing activities
Proceeds from issuance of common stock from exercise of stock options
Repayment of long-term debt
Net proceeds from issuance of debt
Net proceeds from underwritten public offering
Payment of employee tax obligations related to vesting of PSUs and RSUs
Net proceeds from revenue interest financing transaction
Net proceeds from issuance of common stock
At-the-Market Offering Program
Total net proceeds from issuance of common stock
Net cash (used in) provided by financing activities

Net decrease in cash and cash equivalents and restricted cash
Cash and cash equivalents and restricted cash - beginning of period
Cash and cash equivalents and restricted cash - end of period
Supplemental disclosure of cash flow information
Interest paid
Supplemental disclosure of noncash investing and financing activities
Issuance of common stock warrants in connection with long-term debt
Property and equipment purchases included in accounts payable and accrued expenses
Final interest payment fee
Settlement of ESPP liability in common stock
Settlement of 401(k) liability in common stock
Operating lease liabilities arising from obtaining right-of-use assets

Comments